findmyKOL
Clinical trialNCT03942653Active, not recruitingPhase 2Interventional

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

SponsorManish PatelEnrollment20Salivary Gland Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, United States

  • University of Illinois Cancer Center

    Chicago, Illinois, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • Univeristy of Maryland

    Baltimore, Maryland, United States

  • University of Michigan Health System

    Ann Arbor, Michigan, United States

  • University of Minnesota: Masonic Cancer Center

    Minneapolis, Minnesota, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 May 2019
Primary completion
31 Jul 2026
Completion
31 Aug 2026
Last update posted
10 Jul 2026
Registered enrollment
20
Registry id
NCT03942653

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.